We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed at $353.72 in the latest trading session, marking a +1.56% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.06%. Meanwhile, the Dow gained 0.17%, and the Nasdaq, a tech-heavy index, added 0.39%.
Shares of the largest U.S. health insurer witnessed a gain of 13.13% over the previous month, beating the performance of the Medical sector with its gain of 5.06%, and the S&P 500's gain of 3.94%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 28, 2025. The company's earnings per share (EPS) are projected to be $2.87, reflecting a 59.86% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $113.48 billion, indicating a 12.55% growth compared to the corresponding quarter of the prior year.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $16.21 per share and revenue of $448.78 billion. These results would represent year-over-year changes of -41.4% and +12.12%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.82% lower. At present, UnitedHealth Group boasts a Zacks Rank of #4 (Sell).
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 21.49. This denotes a premium relative to the industry average Forward P/E of 14.52.
We can also see that UNH currently has a PEG ratio of 2.25. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.45 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 223, putting it in the bottom 10% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
UnitedHealth Group (UNH - Free Report) closed at $353.72 in the latest trading session, marking a +1.56% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.06%. Meanwhile, the Dow gained 0.17%, and the Nasdaq, a tech-heavy index, added 0.39%.
Shares of the largest U.S. health insurer witnessed a gain of 13.13% over the previous month, beating the performance of the Medical sector with its gain of 5.06%, and the S&P 500's gain of 3.94%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on October 28, 2025. The company's earnings per share (EPS) are projected to be $2.87, reflecting a 59.86% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $113.48 billion, indicating a 12.55% growth compared to the corresponding quarter of the prior year.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $16.21 per share and revenue of $448.78 billion. These results would represent year-over-year changes of -41.4% and +12.12%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.82% lower. At present, UnitedHealth Group boasts a Zacks Rank of #4 (Sell).
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 21.49. This denotes a premium relative to the industry average Forward P/E of 14.52.
We can also see that UNH currently has a PEG ratio of 2.25. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.45 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 223, putting it in the bottom 10% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.